Alexza Moves Lead Candidate AZ-004 Into Phase III For Agitation In Schizophrenia

Firm targets first half of 2010 for NDA filing, R&D Head James Cassella tells "The Pink Sheet" DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet